These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 8294427

  • 1. Interaction of the bHLH-zip domain of c-Myc with H1-type peptides. Characterization of helicity in the H1 peptides by NMR.
    Draeger LJ, Mullen GP.
    J Biol Chem; 1994 Jan 21; 269(3):1785-93. PubMed ID: 8294427
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of cancer cell growth and c-Myc transcriptional activity by a c-Myc helix 1-type peptide fused to an internalization sequence.
    Giorello L, Clerico L, Pescarolo MP, Vikhanskaya F, Salmona M, Colella G, Bruno S, Mancuso T, Bagnasco L, Russo P, Parodi S.
    Cancer Res; 1998 Aug 15; 58(16):3654-9. PubMed ID: 9721875
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A retro-inverso peptide homologous to helix 1 of c-Myc is a potent and specific inhibitor of proliferation in different cellular systems.
    Pescarolo MP, Bagnasco L, Malacarne D, Melchiori A, Valente P, Millo E, Bruno S, Basso S, Parodi S.
    FASEB J; 2001 Jan 15; 15(1):31-33. PubMed ID: 11099487
    [Abstract] [Full Text] [Related]

  • 5. Sequence specific peptidomimetic molecules inhibitors of a protein-protein interaction at the helix 1 level of c-Myc.
    Nieddu E, Melchiori A, Pescarolo MP, Bagnasco L, Biasotti B, Licheri B, Malacarne D, Tortolina L, Castagnino N, Pasa S, Cimoli G, Avignolo C, Ponassi R, Balbi C, Patrone E, D'arrigo C, Barboro P, Vasile F, Orecchia P, Carnemolla B, Damonte G, Millo E, Palomba D, Fassina G, Mazzei M, Parodi S.
    FASEB J; 2005 Apr 15; 19(6):632-4. PubMed ID: 15671156
    [Abstract] [Full Text] [Related]

  • 6. Analysis of the Myc and Max interaction specificity with lambda repressor-HLH domain fusions.
    Marchetti A, Abril-Marti M, Illi B, Cesareni G, Nasi S.
    J Mol Biol; 1995 May 05; 248(3):541-50. PubMed ID: 7752223
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Structural constraints for DNA recognition by Myc and other b-HLH-ZIP proteins: design of oncoprotein analogues.
    Takemoto C, Fisher DE.
    Gene Expr; 1995 May 05; 4(6):311-7. PubMed ID: 7549463
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Distinct DNA binding preferences for the c-Myc/Max and Max/Max dimers.
    Solomon DL, Amati B, Land H.
    Nucleic Acids Res; 1993 Nov 25; 21(23):5372-6. PubMed ID: 8265351
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Variant Max protein, derived by alternative splicing, associates with c-Myc in vivo and inhibits transactivation.
    Arsura M, Deshpande A, Hann SR, Sonenshein GE.
    Mol Cell Biol; 1995 Dec 25; 15(12):6702-9. PubMed ID: 8524235
    [Abstract] [Full Text] [Related]

  • 17. Insights into the mechanism of heterodimerization from the 1H-NMR solution structure of the c-Myc-Max heterodimeric leucine zipper.
    Lavigne P, Crump MP, Gagné SM, Hodges RS, Kay CM, Sykes BD.
    J Mol Biol; 1998 Aug 07; 281(1):165-81. PubMed ID: 9680483
    [Abstract] [Full Text] [Related]

  • 18. Sequence-specific DNA binding by the c-Myc protein.
    Blackwell TK, Kretzner L, Blackwood EM, Eisenman RN, Weintraub H.
    Science; 1990 Nov 23; 250(4984):1149-51. PubMed ID: 2251503
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.